Scholars Central

Conference abstractPublished 28 Mar 2019

Under-representation of vulnerable population in clinical trials impacts negatively on drug development and safety evaluation of new medicine

Authors: Assem S. el Baghdady

Managing Director, AlphaBeta Pharma

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Assem S. el Baghdady”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels